Nippon India Pharma Fund Direct Growth
Get the latest NAV of Nippon India Pharma Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹540.76
▲0.5%1D
NAV as on 12 May 2025
18.02%/per year
Since Inception
▲▼
6663 people have invested ₹ 2.8Cr in Nippon India Pharma Fund Direct Growth in the last three months
Nippon India Pharma Fund Performance vs. Nifty 500
Fund returns vs Benchmark returns vs Category Average returns as on (12-May-25)
The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
Nippon India Pharma Fund Returns Calculator
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
Nippon India Pharma Fund Asset Allocation
as on (31-Mar-25)
Fund Distribution
as on (31-Mar-25)
Equity 99.7%
Debt & Cash 0.3%
Nippon India Pharma Fund Sector Allocation
as on (31-Mar-25)
Sector Allocation
Equity 99.7%
Debt & Cash 0.3%
Top Sector in March was Health
Health
100%
Health
100%
Nippon India Pharma Fund Holdings Details
as on (30-Apr-25)
Equity
Nippon India Pharma Fund Direct Growth Overview
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
| Expense ratio | 0.91% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹8260 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 16.09% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
About Nippon India Pharma Fund
Nippon India Pharma Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Kinjal Desai, Sailesh Raj Bhan. The fund could potentially beat inflation in the long-run.
Key Parameters
- Nippon India Pharma Fund Direct Growth has ₹8260 Cr worth of assets under management (AUM) as on Mar 2025 and is more than category average.
- The fund has an expense ratio 0.9.
Returns
Nippon India Pharma Fund Direct Growth has given a CAGR return of 18.02% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 15.63%, 23.73% and 23.06% respectively.
Holdings
Nippon India Pharma Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of Nippon India Pharma Fund Direct Growth
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Nippon India Pharma Fund Direct Growth has no lock in period.
Fund Manager
Kinjal Desai
Fund Manager of Nippon India Pharma Fund Direct Growth, since 25 May 2018
Sailesh Raj Bhan
Fund Manager of Nippon India Pharma Fund Direct Growth, since 1 April 2005
- AUM of the fund stands at 8.1K Cr as of Mar'25
- AUM increased by 443.9 Cr between Mar'25 and Feb'25
Most Popular Comparisons
Nippon India Pharma Fund
VS
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
Frequently Asked Questions for Nippon India Pharma Fund Direct Growth
What is the current NAV of Nippon India Pharma Fund Direct Growth?
What are the average returns of Nippon India Pharma Fund Direct Growth?
Nippon India Pharma Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 3.32% | 3.32% |
6 Month Returns | -3.49% | -3.49% |
1 Year Returns | 15.63% | 15.63% |
3 Years Returns | 89.42% | 23.73% |
How do I invest in Nippon India Pharma Fund Direct Growth?
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
What is the expense ratio of Nippon India Pharma Fund Direct Growth?
What is net assets under management (AUM) of Nippon India Pharma Fund Direct Growth?
What are the top 5 holdings of Nippon India Pharma Fund Direct Growth?
What is the alpha of Nippon India Pharma Fund Direct Growth?
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Nippon India Pharma Fund Direct Growth | -1 | 1.42 | 1.62 |
What is the beta of Nippon India Pharma Fund Direct Growth??
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Nippon India Pharma Fund Direct Growth | 0.87 | 0.9 | 0.92 |
What is the sharpe ratio of Nippon India Pharma Fund Direct Growth?
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Nippon India Pharma Fund Direct Growth | 0.59 | 0.89 | 1.1 |
What is the standard deviation of Nippon India Pharma Fund Direct Growth?
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Nippon India Pharma Fund Direct Growth | 18.1 | 15.81 | 15.85 |